Gulf International Bank UK Ltd Reduces Position in Church & Dwight Co., Inc. (NYSE:CHD)

Gulf International Bank UK Ltd lessened its holdings in shares of Church & Dwight Co., Inc. (NYSE:CHD) by 1.1% in the 4th quarter, Holdings Channel reports. The fund owned 19,102 shares of the company’s stock after selling 205 shares during the quarter. Gulf International Bank UK Ltd’s holdings in Church & Dwight were worth $2,000,000 at the end of the most recent reporting period.

Several other hedge funds have also made changes to their positions in the company. Mn Services Vermogensbeheer B.V. grew its stake in shares of Church & Dwight by 1.6% in the 4th quarter. Mn Services Vermogensbeheer B.V. now owns 96,000 shares of the company’s stock valued at $10,052,000 after buying an additional 1,500 shares during the period. New York Life Investment Management LLC grew its stake in shares of Church & Dwight by 0.5% in the 4th quarter. New York Life Investment Management LLC now owns 36,459 shares of the company’s stock valued at $3,818,000 after buying an additional 164 shares during the period. SRN Advisors LLC purchased a new stake in shares of Church & Dwight in the 4th quarter valued at approximately $787,000. Oregon Public Employees Retirement Fund grew its stake in shares of Church & Dwight by 0.5% in the 4th quarter. Oregon Public Employees Retirement Fund now owns 21,005 shares of the company’s stock valued at $2,199,000 after buying an additional 103 shares during the period. Finally, Impact Investors Inc purchased a new stake in shares of Church & Dwight in the 4th quarter valued at approximately $592,000. Hedge funds and other institutional investors own 86.60% of the company’s stock.

Church & Dwight Price Performance

Church & Dwight stock opened at $111.32 on Friday. The firm has a market cap of $27.38 billion, a PE ratio of 46.97, a price-to-earnings-growth ratio of 3.32 and a beta of 0.59. Church & Dwight Co., Inc. has a 52-week low of $96.35 and a 52-week high of $113.50. The company has a quick ratio of 1.24, a current ratio of 1.70 and a debt-to-equity ratio of 0.51. The company’s 50 day moving average is $105.71 and its two-hundred day moving average is $104.97.

Church & Dwight (NYSE:CHD) last released its earnings results on Friday, January 31st. The company reported $0.77 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.77. Church & Dwight had a net margin of 9.58% and a return on equity of 20.03%. During the same quarter last year, the firm posted $0.65 EPS. On average, research analysts expect that Church & Dwight Co., Inc. will post 3.7 EPS for the current fiscal year.

Church & Dwight Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, March 3rd. Shareholders of record on Friday, February 14th will be given a $0.295 dividend. The ex-dividend date of this dividend is Friday, February 14th. This is an increase from Church & Dwight’s previous quarterly dividend of $0.28. This represents a $1.18 dividend on an annualized basis and a dividend yield of 1.06%. Church & Dwight’s dividend payout ratio is currently 49.79%.

Analysts Set New Price Targets

Several analysts have recently weighed in on CHD shares. Deutsche Bank Aktiengesellschaft increased their price target on shares of Church & Dwight from $114.00 to $115.00 and gave the company a “buy” rating in a research note on Monday, November 4th. Barclays upped their price objective on shares of Church & Dwight from $90.00 to $93.00 and gave the stock an “underweight” rating in a report on Tuesday, February 4th. Wells Fargo & Company upped their price objective on shares of Church & Dwight from $113.00 to $115.00 and gave the stock an “overweight” rating in a report on Monday, November 4th. Truist Financial upped their price objective on shares of Church & Dwight from $110.00 to $115.00 and gave the stock a “buy” rating in a report on Monday, February 3rd. Finally, Stifel Nicolaus upped their price objective on shares of Church & Dwight from $103.00 to $105.00 and gave the stock a “hold” rating in a report on Monday, February 3rd. Two investment analysts have rated the stock with a sell rating, seven have issued a hold rating and eight have given a buy rating to the stock. According to data from MarketBeat, Church & Dwight currently has an average rating of “Hold” and a consensus target price of $111.47.

Insider Buying and Selling at Church & Dwight

In other Church & Dwight news, Director Ravichandra Krishnamu Saligram sold 10,000 shares of the stock in a transaction that occurred on Monday, December 16th. The shares were sold at an average price of $106.11, for a total value of $1,061,100.00. Following the sale, the director now directly owns 32,500 shares of the company’s stock, valued at approximately $3,448,575. This represents a 23.53 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, EVP Michael Read acquired 1,100 shares of the company’s stock in a transaction on Monday, December 16th. The stock was purchased at an average cost of $106.82 per share, for a total transaction of $117,502.00. Following the completion of the transaction, the executive vice president now owns 2,505 shares in the company, valued at approximately $267,584.10. The trade was a 78.29 % increase in their position. The disclosure for this purchase can be found here. In the last three months, insiders have sold 49,522 shares of company stock valued at $5,487,555. Insiders own 2.00% of the company’s stock.

About Church & Dwight

Church & Dwight Co, Inc engages in the development, manufacture, and marketing of household, personal care, and specialty products. It operates through the following segments: Consumer Domestic, Consumer International, Specialty Products, and Corporate. The Consumer Domestic segment offers household products, such as laundry detergents, fabric softener sheets, cat litter, and household cleaning products, and personal care products including antiperspirants, oral care products, depilatories, reproductive health products, oral analgesics, nasal saline moisturizers, and dietary supplements.